|
1
|
Shen L, Shan YS, Hu HM, et al: Management
of gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thrumurthy SG, Chaudry MA, Hochhauser D
and Mughal M: The diagnosis and management of gastric cancer. BMJ.
347:f63672013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang X, Nie Y, Du Y, Cao J, Shen B and Li
Y: MicroRNA-181a promotes gastric cancer by negatively regulating
tumor suppressor KLF6. Tumour Biol. 33:1589–1597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding L, Xu Y, Zhang W, et al: MiR-375
frequently downregulated in gastric cancer inhibits cell
proliferation by targeting JAK2. Cell Res. 20:784–793. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du Y, Xu Y, Ding L, et al: Down-regulation
of miR-141 in gastric cancer and its involvement in cell growth. J
Gastroenterol. 44:556–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu M, Xia M, Chen X, et al: MicroRNA-141
regulates Smad interacting protein 1 (SIP1) and inhibits migration
and invasion of colorectal cancer cells. Dig Dis Sci. 55:2365–2372.
2010. View Article : Google Scholar
|
|
10
|
Liu Y, Ding Y, Huang J, et al: MiR-141
suppresses the migration and invasion of HCC cells by targeting
Tiam1. PLoS One. 9:e883932014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Li Q, Xu D, et al: hsa-miR-141
downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and
migration. Int J Oncol. 44:459–466. 2014.
|
|
12
|
Gregory PA, Bracken CP, Bert AG and
Goodall GJ: MicroRNAs as regulators of epithelial-mesenchymal
transition. Cell Cycle. 7:3112–3118. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakada C, Matsuura K, Tsukamoto Y, et al:
Genome-wide microRNA expression profiling in renal cell carcinoma:
Significant down-regulation of miR-141 and miR-200c. J Pathol.
216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tamagawa S, Beder LB, Hotomi M, et al:
Role of miR-200c/miR-141 in the regulation of
epithelial-mesenchymal transition and migration in head and neck
squamous cell carcinoma. Int J Mol Med. 33:879–886. 2014.PubMed/NCBI
|
|
17
|
Zhou T, Zimmerman W, Liu X and Erikson RL:
A mammalian NudC-like protein essential for dynein stability and
cell viability. Proc Natl Acad Sci USA. 103:9039–9044. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(2Delta Delta C (T)). Method Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Song S and Ajani JA: The role of microRNAs
in cancers of the upper gastrointestinal tract. Nat Rev
Gastroenterol Hepatol. 10:109–118. 2013. View Article : Google Scholar
|
|
20
|
Zhao G, Wang B, Liu Y, et al: miRNA-141,
downregulated in pancreatic cancer, inhibits cell proliferation and
invasion by directly targeting MAP4K4. Mol Cancer Ther.
12:2569–2580. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen B, Huang T, Jiang J, Lv L, Li H and
Xia S: miR-141 suppresses proliferation and motility of gastric
cancer cells by targeting HDGF. Mol Cell Biochem. 388:211–218.
2014. View Article : Google Scholar
|
|
22
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu SM, Ai HW, Zhang DY, et al: MiR-141
targets ZEB2 to suppress HCC progression. Tumour Biol.
35:9993–9997. 2014. View Article : Google Scholar : PubMed/NCBI
|
